AMP-activated protein kinase (AMPK) is an energy sensor that couples the cellular energy state with basic biological processes. AMPK is thought to be linked with cell division although the underlying mechanisms remain largely unknown. Here, we show that AMPK functionally participates throughout cell division and that AMPK catalytic subunits, especially α2, are sequentially associated with separate mitotic apparatus. Using quantitative phosphoproteomics analysis, we found that the strong direct substrate KIF4A is phosphorylated by AMPK at Ser801. Further analysis revealed that AMPK and Aurora B competitively phosphoregulates KIF4A during mitotic phase due to overlapping recognition motifs, resulting in the elaborate phosphoregulation for KIF4A-dependent central spindle length control. Given the intrinsic energy-sensing function of AMPK, our study links the KIF4A-dependent control of central spindle length with cellular glucose stress.
Introduction
AMP-activated protein kinase (AMPK) is a highly conserved energy sensor composed of a catalytic α subunit, a scaffolding β subunit, and a regulatory γ subunit. In mammals, each subunit is encoded by multiple genes (α1, α2, β1, β2, γ1, γ2, and γ3), generating at least 12 heterotrimeric combinations. AMPK is activated by stimuli such as nutrient deprivation, hypoxia, and other cellular stresses that increase the AMP/ATP or ADP/ATP ratios, where in the binding of AMP or ADP to the γ subunit induces a conformational change that facilitates phosphorylation by upstream kinases while inhibiting dephosphorylation by protein phosphatases. Activated AMPK then promotes catabolic pathways to generate ATP while switching off ATPconsuming pathways thereby restoring energy homeostasis (Hardie et al., 1998 (Hardie et al., , 2012 Carling et al., 2011) .
Given its role as a central kinase in coordinating cell growth with energy status, the functions of AMPK in metabolic regulation have been widely studied (Hardie, 2011; Mihaylova and Shaw, 2011) . However, the emerging role of AMPK in cell division which is not directly viewed as a metabolic process is poorly understood. A direct linkage between AMPK and cell division was first suggested in Drosophila system, in which defective mitotic cells containing lagging or polyploid chromosomes were frequently observed in AMPK-null embryos and larval brains (Lee et al., 2007) . In human cancer-derived epithelial cells, AMPK activity is increased during mitosis and AMPK depletion will induce an early mitotic delay (Vazquez-Martin et al., 2009a, b; Thaiparambil et al., 2012) . Multiple cell divisionassociated substrates identified via MS-based AMPK substrate screening in HeLa cells (Banko et al., 2011) also support potential functions of AMPK in mitosis. However, the exact function of AMPK during distinct mitotic phases and the role of its energysensing function remain unclear.
In this study, we systematically investigated the function and localization of AMPK subunits during distinct mitotic phases in HeLa cells. Combined with an MS-based quantitative phosphoproteomic study, we identified KIF4A as a strong AMPK substrate candidate and explained how AMPK functions in KIF4A-dependent central spindle length regulation.
Results

Cytoskeleton-and cell division-associated proteins are identified as AMPK candidate substrates
To identify potential substrates and to better understand the physiological function of AMPK, we performed stable isotope dimethyl-labeled quantitative phosphoproteomics of HepG2 cells following 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR, an activator of AMPK)-induced AMPK activation. Total cellular protein isolated from the AICAR-treated and untreated groups was subjected to trypsin digestion, and the resulting peptides were subjected to either 'light' or 'heavy' isotope dimethyl labeling. Then, phosphopeptides from the 1:1 mixture were enriched by immobilized metal affinity chromatography (IMAC), fractionated via hydrophilic interaction chromatography (HILIC), and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) ( Figure 1A) . The AICAR-stimulated activation of AMPK was confirmed by increased phosphorylation of the classical substrate acetyl-CoA carboxylase (ACC) ( Figure 1B) .
By combining our MS results with bioinformatics analyses, from 565 quantified phosphopeptides, we screened out 22 phosphopeptides, because their phosphosites matched well with the consensus AMPK recognition motif ( Figure 1C ). As expected, the phosphopeptide heavy/light ratio of the known AMPK substrate ACACA at Ser80 was up-regulated by 12.29-fold, which was consistent with our previous WB results ( Figure 1B ), thus providing a positive control for our quantitative phosphoproteomics system. Given its role as a sensor of cellular energy status, several candidate substrates of AMPK were identified that are involved in metabolism and protein expression. Moreover, a high percentage of cytoskeleton-and cell divisionassociated proteins, such as KLC2, KLC4, TM201, and KIF4A, were identified. Among these candidates, the KLC2 Ser582 phosphosite has previously been characterized as an AMPK phosphosite (Amato et al., 2011) . KIF4A, a chromosomeassociated kinesin, was up-regulated 10.80-fold at Ser801 site upon AICAR stimulation ( Figure 1C and D) , comparable to the up-regulation observed in ACACA Ser80 site.
AMPK contributes to the control of cell division and central spindle length
To determine the roles of AMPK during cell division, we first examined the mitotic index in HeLa cells by depleting AMPK catalytic subunits, α1, α2, or both ( Figure 2A) . Treatment with either α1 or α2 RNAi increased the mitotic index, and the combined RNAi treatment further increased the mitotic index to 14.68% compared with 5.28% in control cells ( Figure 2B ). This combined siRNA treatment was therefore used for the subsequent experiments to prevent functional compensation between AMPK catalytic isoforms. This increase of mitotic index upon AMPKα knockdown was further confirmed in HUVEC and 293 L.P. cell lines (Supplementary Figure S1A and B) . We then monitored early mitotic progression from chromosome condensation to anaphase onset in eGFP-H2B-expressing HeLa cells. Consistent with previous results (Thaiparambil et al., 2012) , AMPKα RNAi increased the duration of this period to 98 min from 52 min (Figure 2C and D; Supplementary Videos S1 and S2), indicating that AMPK depletion induced a delay of early mitosis. Because the majority of cells ultimately progressed to cytokinesis, we then monitored the progression from chromosome separation to abscission in eGFP-α tubulin-expressing HeLa cells. AMPKα depletion also induced a cellular abscission delay (Figure 2E and F; Supplementary Videos S3 and S4) . examined by western blot. HeLa cells stably expressing eGFP-H2B were treated with siControl or siAMPK α1 or/and α2, the expression level of AMPKα was analyzed after 48 h transfection. (B) SiAMPK α1 or/and α2 increased the mitotic index (mean ± SD, n is shown in graph; *P < 0.05, ***P < 0.001). (C and D) AMPKα depletion induces an early mitotic delay. For live imaging, HeLa cells were transfected with either siControl or siAMPK α1 and α2 for 24 h and then blocked with thymidine for further 17 h. After 8 h release, cells were imaged every 3 min with a spinning-disk cofocal microscope to record the process of mitosis. The maximum intensity-projected images of representative eGFP-H2B-expressing HeLa cells are shown at the time indicated in C. The duration time from prometaphase to anaphase onset (indicated by dotted orange lines and arrows) are plotted on graph D. Values (mean ± SD) were from three independent experiments. ***P < 0.001. (E-G) AMPKα depletion induces an increase of cytokinesis duration and decrease of central spindle length. The maximum intensity-projected images of representative eGFP-α tubulin-expressing HeLa cells are shown at the time indicated in E. Cytokinesis time from anaphase onset to abscission (indicated by blue arrows) is shown in graph F. The anaphase central spindle length (indicated by green arrows) was measured and plotted in graph G. Values (mean ± SD) of n ≥ 71 cells in each condition were from three independent experiments. ***P < 0.001. (H and I) AMPK activity correlated with the central spindle length. Thymidine-synchronized eGFP-α tubulinexpressing HeLa cells were released by washout, and treated with DMSO, 1 μM Compound C, or 1 mM AICAR for 1 h after 9 h release. Then frames were taken every 1 min with spinning disk confocal microscopy. Maximum intensity-projected images of representative cells are shown in H. Time zero referred to the point at which anaphase onset (orange dotted line marks the late anaphase transition and orange arrow indicates the furrowing). The central spindle length (indicated by green lines in H) was plotted as a function of time in graph I (mean ± SD, n = 11, 6, 6 in each condition). Scale bar, 10 μm.
Moreover, in both H2B and α tubulin-expressing HeLa cells we observed a slight but statistically significant decrease in late anaphase central spindle size (after furrow ingression, also see dotted orange line and arrow in Figure 2H ) when AMPKα was depleted ( Figure 2C , E, and G; Supplementary Figure S1C , Videos S1' and S2'). We therefore asked whether this was associated with AMPK activity. Indeed treatment with the AMPK inhibitor Compound C slowed down the kinetics of midzone formation, resulting in shortened central spindle length during late anaphase (Figure 2H and I; Supplementary Figure  S1D and E, Videos S5, S6, S3' and S4'). In contrast, treatment with the AMPK activator AICAR induced an accelerated and persistent elongation of the midzone, that did not terminate normally after furrow ingression, resulting in a markedly elongated central spindle during late anaphase (Figure 2H and I;
Supplementary Figure S1D and E, Videos S7 and S5'). Together, these data indicate that AMPK is required for proper cell division and that AMPK activity is correlated with central spindle length.
AMPKα2 sequentially binds to separate mitotic apparatus
To investigated the localization of the AMPK subunits during mitosis, we transfected 293T cells with GFP labeled AMPK subunits. During interphase, unlike the predominantly cytoplasmic expression of eGFP-AMPKα1, β2 and γ2, eGFP-AMPKα2 localized both to the cytoplasm and the nucleus, supporting the chromosome modification function of AMPKα2 (Bungard et al., 2010) . When cells entered mitosis, eGFP-AMPKα2 transiently and sequentially bound to the centrosomes, spindle, midzone and midbody bulge, which became clearer when cells were Figure 2 Continued subjected to a brief extraction ( Figure 3A ; Supplementary Figure S2A ). EGFP-AMPKα1 showed similar but a little weaker localization as eGFP-AMPKα2 did, but neither eGFP-AMPKβ2 nor eGFP-AMPKγ2 bound to centrosomes, the midzone or the midbody bulge (Supplementary Figure S2B) , which suggest that the AMPK catalytic subunit might be the direct binding component during mitosis.
AMPK phosphorylates KIF4A at Ser801
The eGFP-AMPKα2 in midzone during anaphase co-localized with endogenous KIF4A (Figure 3A) , a candidate substrate of AMPK identified in our MS study ( Figure 1C and D) . The possible interaction between AMPK α2 and KIF4A was further examined by a co-immunoprecipitation assay ( Figure 3B ). Analyzing a series of KIF4A truncations, we narrowed down the interaction domain of KIF4A to the coiled-coil region (Supplementary Figure S3A) , which contains the previously identified phosphosite Ser801. We then asked whether KIF4A can be directly phosphorylated by AMPK at Ser801.
Bioinformatics analysis showed that the highly conserved amino acid sequence surrounding Ser801 matches the consensus AMPK phosphorylation motif except that the hydrophobic residue at P-5 is shifted to P-6 ( Figure 3C ). By in vitro kinase assays using [
32 P]-labeled ATP along with purified CaMKKβ, AMPK and truncated KIF4A (710-912 aa, WT or S801A) proteins ( Figure 3D ), we found that only activated AMPK that had been pre-incubated with CaMKKβ was able to phosphorylate wildtype KIF4A, and that the [ 32 P] signal was dramatically reduced when Ser801 was converted to alanine ( Figure 3E ). Using a specific polyclonal antibody raised against a synthetic Ser801 phosphopeptide, we determined that KIF4A pSer801 occurs only in the presence of active AMPK kinase, and that recognition by anti-pSer801 antibody was abolished by the S801A mutant ( Figure 3F ). Thus, we demonstrated that AMPK directly phosphorylates KIF4A at Ser801 in vitro.
We next assessed AMPK-induced KIF4A phosphorylation in cultured cells. In agreement with our previous MS findings, AICAR treatment increased KIF4A Ser801 phosphorylation in a time-dependent manner in several human cell lines, including HepG2 (Supplementary Figure S3B) , U2OS (Supplementary Figure S3C) , and HeLa ( Figure 3G ). To eliminate the possibility of an AMPK-independent response to AICAR, we used siRNAs to specifically deplete AMPK. Depleting AMPKα blocked the AICARinduced enhancement of KIF4A Ser801 phosphorylation ( Figure 3G ). In addition, depleting KIF4A abrogated recognition by anti-pSer801 ( Figure 3G ). Thus, these data confirm that AMPK can phosphorylate KIF4A at Ser801 both in vitro and in vivo.
AMPK regulates the central spindle length by phosphorylating KIF4A at Ser801
Consistent with the dominant role of KIF4A in regulating central spindle length (Kurasawa et al., 2004; Hu et al., 2011) , the central spindle microtubules were poorly organized and the length was increased to 14-16 μm in KIF4A deficient cells ( Figure 4A , B, and D), which would not be further affected by treatment with either AMPK activator or inhibitor ( Figure 4A , B, and D), suggesting that the fluctuation of central spindle size in response to AMPK activity is dependent on the regulation of KIF4A.
As with the classic AMPK substrate ACC, phosphorylation level of KIF4A at Ser801 was decreased or increased when AMPK activity was inhibited or activated, respectively ( Figures  3G, 4A , and 6C). We therefore studied whether the regulation of central spindle size in response to AMPK activity was further dependent on the phosphorylation of KIF4A at Ser801. We replaced endogenous KIF4A by transfecting cells with siRNA aganist the KIF4A 3′UTR followed by infection with virus expressing either wild-type GFP-KIF4A or an S801A or S801D mutation ( Figure 4A ). Exogenous GFP-KIF4A expression of all three GFP-KIF4A constructs rescued the poor organization of central spindle microtubules ( Figure 4C ), but induced different late anaphase central spindle lengths that were comparable to those measured in the respective AMPK inhibited or activated cells ( Figure 2H and I; Supplementary Figure S1D and E), which means S801A-KIF4A induced a shortened length and S801D-KIF4A induced an increased length when compared with WT-KIF4A ( Figure 4D ). In addition, late anaphase central spindle length in cells rescued using either S801A-KIF4A or S801D-KIF4A mutation was not further influenced by treatment with an opposing compound ( Figure 4C and D). These data suggest that AMPK might regulate the central spindle length via phosphorylating KIF4A at Ser801.
KIF4A ATPase activity is phosphoregulated by AMPK and Aurora B in a mutual exclusive manner
As a plus-end directed microtubule kinesin, KIF4A regulates the dynamic behavior of central spindle microtubules by blocking their further elongation (Zhu and Jiang, 2005; Nunes Bastos et al., 2013) , we therefore tested the possibility that AMPK phosphorylation inhibits KIF4A motor activity. To this end, we performed a microtubule-stimulated kinesin motor ATPase assay using recombinant full-length KIF4A in vitro ( Figure 5A ). In the absence of full-length KIF4A, active AMPK showed the same background signal as buffer. Pre-incubating full-length KIF4A with buffer, CaMKKβ or inactive AMPK yielded similar microtubule-stimulated ATPase activity, whereas pre-incubation with active AMPK resulted in an unexpected increase in KIF4A ATPase activity ( Figure 5B ).
We next asked what might lead to this contradiction. Previous work has suggested that Aurora B can increase KIF4A ATPase activity via phosphorylation at Thr799 (Nunes . Intriguingly, both the Thr799 and Ser801 phosphosites are located within a highly conserved sequence of KIF4A ( Figure 5C ). Because the substantial overlap between the AMPK and Aurora B recognition motifs at these two sites may be functionally relevant, we then generated specific phosphopeptide antibodies against Thr799 to facilitate detection. Using in vitro kinase assays, we found that active AMPK and Aurora B phosphorylated KIF4A at Ser801 and Thr799 respectively in a time- dependent manner ( Figure 5D ). However, the Aurora B-dependent phosphorylation of Thr799 was blocked when KIF4A was fully phosphorylated at Ser801 by AMPK, and vice versa ( Figure 5E ). Consistent with these results, the phosphormimic mutation S801D completely blocked Aurora B induced phosphorylation at Thr799 ( Figure 5F ) and the phospho-mimic T799D mutation significantly impaired AMPK-induced phosphoylation at Ser801 ( Figure 5G ). In contrast, KIF4A S801A and T799A were successfully phosphorylated at the remaining site by Aurora B and AMPK, respectively ( Figure 5H ). In the above kinase assays, isotopes and/or antibodies were used to exclude any potential non-specific or disturbed binding of antibodies induced by the mutations. Although both antibodies specifically recognized the phosphorylation state of their corresponding sites, they failed to recognize the phospho-mimic mutations. The weakened but detectable anti-pSer801 signal from the T799D mutant protein induced by active AMPK ( Figure 5G) is consistent with the substrate recognition characteristics of AMPK, which tolerates an aspartic residue at P-2 if the basic side chain is fully satisfied. However, acidic residue replacement greatly impairs recognition by AMPK, and when the threonine at P-2 is phosphorylated by Aurora B, the disruption of the basic side chains further interferes with recognition ( Figure 5E ). Thus, in the subsequent in vivo experiments, we substituted the T799D mutation with T799D/S801A mutations to better mimic the unique phosphorylation condition of KIF4A. We found that the T799A/S801D double mutation is functionally equivalent to the S801D mutation (S801D in Figure 4C and D; T799A/S801D in Figure 7C and E).
Altogether, these results suggest that the two sites flanking the conserved sequence contain two different embedded motifs that are recognized separately by Aurora B and AMPK in a mutually exclusive manner. This property might also explain why the hydrophobic residue N-terminal to Ser801 is found at P-6 rather than at P-5 as in most optimal AMPK substrates ( Figure 3C) .
We then compared the increased microtubule-stimulated KIF4A ATPase activity resulting from the two separate phosphorylations. Although AMPK phosphorylation increased the ATPase activity of KIF4A, Aurora B phosphorylation resulted in a stronger increase ( Figure 5I ), which might be consistent with phorylation increases KIF4A ATPase activity. Kinesin ATPase assay were performed using 100 nM recombinant full-length KIF4A. Full-length KIF4A was prephosphorylated with 10 nM active AMPKα2β2γ2, with 10 nM inactive AMPKα2β2γ2 and 5 nM CaMKKβ as control (n = 3). (C) Schematic of overlapped AMPK and Aurora B phoshorylation consensus motifs at KIF4A. (D-H) AMPK and Aurora B phosphorylate KIF4A at separate site in an exclusive way. In vitro kinase assays were performed using 100 nM KIF4A (701-912 aa; WT for D and E; WT and S801D for F; WT and T799D for G; WT, T799A, S801A, and T799A/S801A for H), 10 nM active AMPKα2β2γ2, and/or 20 nM Aurora B. 60
# in E means that KIF4A was incubated with the indicated kinase firstly for 60 min (experimental details available in Materials and methods). For autoradiography, 5 μCi γ-[ 32 P] ATP was added per reaction. Indicated antibodies were used for immunoblotting. (I) Aurora B phosphorylation more efficiently increases KIF4A ATPase activity. Kinesin ATPase assay were performed using 100 nM recombinant full-length KIF4A. Full-length KIF4A was prephosphorylatd with 10 nM active AMPKα2β2γ2 or 20 nM Aurora B (n = 2).
the more powerful kinase function of Aurora B during mitosis. This result suggests that Aurora B-dependent phosphorylation could more efficiently terminate the elongation of the central spindle microtubules and that, in addition to increasing KIF4A ATPase activity moderately, AMPK-dependent phosphorylation would limit the effect of Aurora B on KIF4A. This alternative and mutual exclusive phosphorylation modifications might be a more precise regulation way of KIF4A activity.
KIF4A is competitively phosphoregulated by AMPK and Aurora B during mitosis
We next examined the phosphorylation status of KIF4A in vivo. First, we synchronized HeLa cells in G1/S phase and released them to progress to mitosis using the expression level of cyclin A and cyclin B1 and the phosphorylation level of Histone 3 at Ser10 (Wei et al., 1998; Goto et al., 2002) as indicators. Before the M-phase transition, Ser801 exhibited a sustained phosphorylation, whereas after cells entered M phase, both Thr799 and Ser801 were increasingly phosphorylated ( Figure 6A ). We next arrested cells at mitotic phase and released them to progress to distinct mitotic stages, both Thr799 and Ser801 phosphorylations were detected and persisted from metaphase to telophase but declined after the onset of anaphase ( Figure 6B ). This finding is in agreement with a previous quantitative phosphoproteomic study in which KIF4A phosphorylation at both Thr799 and Ser801 was identified at distinct mitotic stages (Malik et al., 2009) . The specificity of both antibodies was confirmed by the disappearance of signals in KIF4A-depleted cells (Supplementary Figure S4A and B). Thus, these results suggest that during interphase KIF4A is phosphorylated by AMPK at Ser801, whereas upon entering M-phase KIF4A can be phosphorylated by either AMPK or Aurora B.
Consistent with that the phosphoregulation of KIF4A at Thr799 but not at Ser801 was temporal restricted at M phase ( Figure 6A ), we found that in asynchronized cells when the antipKIF4A Ser801 signal was inhibited or increased by AMPK inhibitor or activator treatment, the anti-pKIF4A Thr799 signal did not obviously increase or decrease ( Figure 6C) . Interestingly, Aurora B inhibitor ZM447439 treatment greatly increased the phosphorylation of KIF4A at Ser801 although the low phosphorylation of KIF4A at Thr799 was not further decreased (Supplementary Figure S5A) . Whereas, in synchronized cells, the increased phosphorylation of KIF4A at Ser801 markedly reduced the phosphorylation of KIF4A at Thr799 at each stage ( Figure 6B) , suggesting the possibility of competitive phosphoregulation of KIF4A by AMPK and Aurora B during mitotic phase.
The detected phosphorylation signals of KIF4A prior to anaphase onset ( Figure 6A and B) support that chromosomal KIF4A can be phosphoregulated by AMPK or Aurora B. However, immunofluorescence staining of fixed mitotic cells using our antibodies only revealed specific phosphorylation signals at the anaphase central spindle (Supplementary Figure S4C) . We then quantified both the intensity of KIF4A and intensity ratio of pKIF4A/KIF4A at the central spindle of cells entering late anaphase, in which the intensity of central spindle KIF4A was not greatly affected by AMPK activity changing compared with the one at early anaphase (Supplementary Figure S5B and C; Figure 6D and E). The results showed that when the intensity ratio of pSer801 to KIF4A at the late anaphase central spindle was decreased by Compound C treatment, the ratio of pThr799 to KIF4A increased accordingly ( Figure 6D and F) . The depletion of AMPK yielded similar results (Supplementary Figure S5D and  E) . Conversely, the increased ratio of pSer801 to KIF4A following AICAR treatment could counteract that of pThr799 to KIF4A ( Figure 6D and F) . Due to the disturbed progression of mitosis and altered central spindle organization, we were unable to examine this competition using an Aurora B inhibitor. However, our results support the view that KIF4A is phosphoregulated by AMPK and Aurora B during mitosis.
The central spindle translocation behavior of KIF4A is phosphoregulated by AMPK and Aurora B
To answer why cells need this mode of phosphoregulation for KIF4A, we created a series of mutations ( Figure 7A ). Endogenous KIF4A was replaced by treating cells with siRNA against the KIF4A 3′UTR followed by infection with lentivirus encoding eGFP-tagged KIF4A ( Figure 7B) . The different mutant forms of eGFP-tagged KIF4A were all successfully localized to chromatin but exhibited different central spindle assembly behaviors during anaphase. Consistent with previous work (Nunes , wide-type KIF4A gradually accumulated at the central spindle ∼4-6 min after anaphase onset, whereas T799A/S801A (dual phosphodefective) mutants failed to translocate to the central spindle (Figure 7C and D; Supplementary Videos S8 and S9). Interestingly, both the two single phosphodefective mutants KIF4A (T799A or S801A) were able to assemble at the central spindle, however, with T799A being slower and S801A being faster than wide-type KIF4A (Figure 7C and D; Supplementary Videos S10 and S11). These results suggest that the site-dependent phosphoregulation at these two residues is critical for KIF4A to translocate to the central spindle, and that one site can functionally compensate for the other site if being blocked. This view is further supported by the finding that T799A/S801D-KIF4A behaves similarly to T799A-KIF4A while T799D/S801A-KIF4A behaves similarly to S801A-KIF4A (Figure 7C and D; Supplementary Videos S12 and S13). The different kinetic behaviors induced by different mutations therefore resulted in a negatively correlated anaphase central spindle length: longer central spindles were found in cells carrying the T799A or T799A/S801D mutation, whereas shorter central spindles were found in those with the S801A or T799D/S801A mutation ( Figure 7C ). We quantified intensity of the central spindle KIF4A labeling compared with that of chromosomal KIF4A in the same cell to reduce the variance resulting from different protein expression levels.
The weakened late anaphase assembly exhibited by S801D-KIF4A ( Figure 4C ) or T799A/S801D-KIF4A and T799A-KIF4A ( Figure 7D and E) compared with S801A-KIF4A and T799D/S801A-KIF4A ( Figures 4C,  7D and E) is consistent with the differential ATPase activity Figure 6 KIF4A is competitively phosphorylated by AMPK and Aurora B during mitotic phase. (A and B) Immunoblotting analyses of the phosphorylation status of KIF4A in one cell cycle context. In A, cells were synchronized by double thymidine block and harvested at indicated time after second release. In B, thymidine-synchronized HeLa cells were further arrested at G2/M by nocodazole treatment. AICAR treated or non-treated cells were collected at indicated time after released. (C) The phosphorylation of KIF4A at Ser801 is altered by AMPK activity changing. Asynchronized HeLa cells were treated with 2.5 μM Compound C or 1 mM AICAR for indicated times. (D) Coimmunostaining of total KIF4A and pT799 or pS801 at the central spindle. HeLa cells were synchronized with thymidine and released by washout after 8 h release, cells were treated with DMSO, 1 μM Compound C, 1 mM AICAR for a further 1 h. Then, cells were fixed and stained with mouse anti-KIF4A and rabbit anti-pSer801 or rabbit anti-pThr799. DNA was stained with Hoechst. Cells undergoing late anaphase were analyzed. Representative images from one independent experiment are shown. Scale bar, 5 μm. (E) Quantitation of the total KIF4A intensity at the central spindle in D. Total KIF4A intensity in either Compound C or AICAR treated cells were normalized by that in control cells (mean ± SD, ≥36 cells from three independent experiments were analyzed for each treatment). (F) Quantitation of phosphorylated KIF4A intensity at the central spindle in D. The intensity level of pS801 or pT799 are quantified over that of total KIF4A at the central spindle in each cell. The values from three independent experiments are plotted in graph (mean ± SD, ≥16 cells were analyzed for each anti-pKIF4A staining in each treatment; *P < 0.05, ***P < 0.001). conferred by AMPK-and Aurora B-dependent phosphorylation. The greatly affected KIF4A intensity at early anaphase central spindle (Supplementary Figure S5B and C) but not at late anaphase central spindle ( Figure 6D and E) by AMPK activity changing also support that the central spindle translocation behavior of KIF4A can be modulated by competitive phosphoregulation between AMPK and Aurora B.
In accordance with capacity for central spindle assembly, the diffused microtubule overlapping of PRC1 at central spindle induced by KIF4A depletion was rescued by exogenously expressing either single phosphodefective or phospho-mimic but not the dual phosphodefective KIF4A (Figure 7E and F) . Because PRC1 binding is essential for KIF4A central spindle translocation (Kurasawa et al., 2004; Zhu and Jiang, 2005; Zhu et al., 2006) , we also investigated the interaction between KIF4A and PRC1. However, this interaction was not greatly affected by any type mutation even the T799A/S801A mutations in our co-immunoprecipitation experiments ( Figure 7G ), which suggests that the differential motor activity induced by site-dependent phosphorylation might be a primary mechanism to regulate the central spindle assembly behavior of KIF4A.
KIF4A-dependent central spindle length responses to glucose stress
We then asked the connection between the intrinsic energysensing function of AMPK and KIF4A-dependent central spindle length control. Interestingly, phosphorylation of KIF4A at Ser801 was rapidly increased by glucose deficiency and/or deprivation stress both in asynchronized ( Figure 8A ) and mitotic ( Figure 8B ) cells. And that for mitotic cells the enhanced phosphorylation of pKIF4A Ser801 would counteracted the phosphorylation of pKIF4A Thr799 ( Figure 8B ), which therefore increased the central spindle length as AICAR did ( Figure 8C and D) , suggesting that changes of AMPK activity induced by glucose stress can alter the central spindle length.
Thus, we establish a link between KIF4A-dependent central spindle length control and cellular glucose stress, which can be explained in the following model. In normal condition, KIF4A ATPase activity was modulated to construct a central spindle with appropriate size by balancing Aurora B-and AMPKdependent phosphorylations. Inhibited AMPK activity or AMPK depletion would induce an excess of Aurora B-dependent phosphorylation of KIF4A which prematurely blocks central spindle elongation and shortens the central spindle length. Whereas, after sensing a deficient cellular glucose condition, elevated AMPK activity would increase the competitiveness of AMPKdependent phosphorylation and induce an undisturbed but elongated central spindle length ( Figure 8E ). Given the relevance of ATP consumption to KIF4A activity and the differential KIF4A ATPase conferred induced by Aurora B-and AMPKdependent phosphorylations ( Figure 5I ), this competitive phosphoregulation may act as a buffer for KIF4A to support the functional central spindle assembly in adapting glucose stress.
Discussion
After anaphase onset, central spindle assembly is initiated between separate chromosomes with the aid of a diverse set of microtubule-associated proteins and kinesins (Mishima et al., 2004; Glotzer, 2009; Uehara and Goshima, 2010; Fededa and Gerlich, 2012; Maton et al., 2015; Uehara et al., 2009) . The organization of the core structure of the central spindle, which serves as a platform for the recruitment of proteins essential for late mitotic events, is chiefly regulated by the PRC1-KIF4A module. PRC1 bundles the interdigitated anti-parallel microtubules, while KIF4A regulates the plus-end dynamics of microtubules (Jiang et al., 1998; Kurasawa et al., 2004; Bieling et al., 2010; Shrestha et al., 2012; Zhu et al., 2006; Subramanian et al., 2010) . Our study further elucidates how KIF4A activity is regulated by phosphorylation and supports the hypothesis that the central spindle assembly behavior of KIF4A can be regulated by phosphorylation-dependent activity modulation (Hu et al., 2011; Nunes Bastos et al., 2013) . Although both coil-coiled and tail regions of KIF4A are required for PRC1's binding (Zhu and Jiang, 2005; Subramanian et al., 2013) , the interaction with PRC1 was not obviously affected by these two sites dependent phosphorylation ( Figure 7G) . Combined with the previous finding that Aurora B phosphorylated, nonphosphorylated and even the coilcoiled region-lacking KIF4A show similar microtubule binding, we hypothesize that the differential activation mediated by Aurora B and AMPK might be the primary mode of regulating KIF4A, potentially via phosphorylation-induced discriminating conformational changes that release the auto-inhibited motor activity of head domain (Hackney, 2007) .
Phosphatases are therefore required for the dynamic turnover of phosphorylation at these two sites. PP2A-B56γ and -ε have been found to oppose the Aurora B-dependent phosphorylation of KIF4A at Thr799, and then further work is needed to examine which phosphatase recognizes phosphorylated Ser801 (Bastos et al., 2014) . We observed a declining phosphorylation at both Thr799 and Ser801 sites during the metaphase to anaphase transition (Figures 6B and 8B; Supplementary Figure S4B ), which might be consistent with the activation of phosphatases including PP1 and PP2A with falling CDK1 activity during transition (Bollen et al., 2009; Castilho et al., 2009; Cundell et al., 2013 Cundell et al., , 2016 Wu et al., 2009; Wurzenberger and Gerlich, 2011) . Moreover, the clearly increased Ser801 phosphorylation in asynchronized cells upon Aurora B inhibition (Supplementary Figure S5A) suggested a possibility of Aurora B interferes with the dephosphorylation of KIF4A at Ser801. Thus, the phosphoregulation of KIF4A during mitosis requires further investigation regarding the opposing feedback loop between PP2A-B56γ and -ε and Aurora B.
In addition to the well-described function of KIF4A at the central spindle during anaphase, two major functions of KIF4A as a chromokinesin during early mitosis have been reported: (i) KIF4A helps to shape the characteristic mitotic chromosome structure by serving as a chromosome scaffold protein in conjunction with condensin and topoisomerase IIα; and (ii) KIF4A contributes to the regulation of chromosome movement by Anaphase central spindle length in each condition was measured and shown as mean ± SD of ≥38 cells per condition from three independent experiments. **P < 0.01. (E) A model for AMPK activity associated central spindle length control. Following the onset of anaphase, central spindle is built from anti-parallel microtubules which are bundled by PRC1 at the overlapped central region. KIF4A activity is regulated by balancing AMPK-and Aurora B-dependent phosphorylations, which determines an appropriate central spindle length. When AMPK activity is inhibited, increased pThr799 will over-activate KIF4A and over-suppresss microtubule plus-end dynamics, which thereby shortens the central spindle length; when AMPK activity is augmented, increased pSer801 over-counteracts Aurora B-dependent phosphorylation, which will not efficiently block microtubule plus-end growth, and thereby elongate the central spindle length.
controlling either kinetochore-microtubule dynamics or the chromatin arms and nearby spindle microtubule dynamics (Mazumdar et al., 2004; Samejima et al., 2012; Stumpff et al., 2012; Wandke et al., 2012; Takahashi et al., 2016) . Our results suggest that the phosphorylation of KIF4A at Thr799 and Ser801 may not be restricted at the anaphase central spindle ( Figure 6A and B) (Malik et al., 2009) . Therefore, whether and how KIF4A is phosphoregulated during early mitosis deserve further evaluation. As an unique nuclear localized kinesin, KIF4A is also required to maintain compacted chromatin and to modulate gene transcription and S-phase progression during interphase (Mazumdar et al., 2011) . Intriguingly, AMPK can regulate gene transcription by histone-dependent epigenetic regulation, which links gene transcription with cellular adaptation to energy stress (Bungard et al., 2010; Xu et al., 2014) . Our work identifies KIF4A as a new substrate for AMPK, another connection in AMPK-dependent chromosomal modification. The sustained phosphorylation of KIF4A at Ser801 during interphase corroborates the possible AMPK-KIF4A transcriptional regulatory pathway ( Figure 6A ). In addition to the rapid response to glucose deficiency or deprivation stress ( Figure 8A and B) , the AMPKdependent phosphorylation of KIF4A at Ser801 also increases in response to ischemic stress (Schaffer et al., 2015) , suggesting that KIF4A is a general phosphor-substrate of AMPK in the adaptation to nutrient stress.
Our work suggests that AMPK is required for appropriate cell division. We cannot exclude that other substrates of AMPK might also be involved during this process, since both, the early mitotic phase and cellular abscission delays induced by AMPK depletion, cannot be well explained by AMPK-dependent phosphorylation of KIF4A. However, our initial observation of the spindle and the midbody bulge assembly of AMPK catalytic subunits, especially α2, and our proteomics study offer new insights into how AMPK is involved in early mitotic and cellular abscission regulations ( Figure 3A ; Supplementary Figure S2A and B). In addition, while LKB1-or CaMKKβ-dependent phosphorylation at Thr172 (Hawley et al., 1996 (Hawley et al., , 2005 Woods et al., 2003) is required for AMPK activation, the cellular AMP/ATP and ADP/ ATP ratio can further modulate AMPK activity, taking into account that cytoskeletal remodeling during cell division is an energy-intensive process, how to restrict AMPK catalytic subunits to specific area at distinct mitotic stages is an open and interesting question.
Materials and methods
Protein isolation, digestion, labeling, phopshopeptides enrichment, and LC-MS/MS For cell extract preparation, cells were treated with or without 1 mM AICAR for 3 h, and then lysed with RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) containing phosphatase inhibitor cocktail (PhosSTOP, Roche) and protease inhibitor cocktail (COMPLETE, Roche) on ice after washed three times with PBS. The supernatant was collected after centrifugation at 16000× g for 0.5 h. Protein extraction were then mixed with 3 volumes of protein precipitation solution (50% acetone, 50% ethanol and 0.1% acetic acid) and placed on ice for 2 h, then centrifuged at 10000× g for 20 min. The protein pellets were resuspended in a buffer containing 8 M urea, 0.2 M Tris-HCl pH 8 and 4 mM CaCl 2 . The protein were reduced with DTT, alkylated with iodoacetamide, and then digested with trypsin. The digested peptides were desalted with a SepPak C18 cartridge (Waters), dried in a SpeedVac, dimethyl-labeled with either CH 2 O (light labeled, the control sample) or CD 2 O (heavy labeled, AICAR-stimulated sample). The dimethyl-labeling experiment was performed following by a previously reported protocol (Boersema et al., 2008) . The light-and heavy-labeled peptides were mixed at a ratio of 1:1, and then phosphopeptides were enriched using IMAC. Enriched phosphopeptides were separated using HILIC into 14 fractions. Each fraction was desalted using a Zip TipC18 micropipette tip (Millipore), dried with a SpeedVac, and stored at -80˚C before the LC-MS/MS analysis.
For LC-MS/MS analyses, a QSTAR ELITE mass spectrometer (Applied Biosystems) coupled with an online Eksigent nano MDLC system utilizing a nanospray ionization source was used. For the identification and quantification, Raw data from QSTAR ELITE were loaded by Mascot Daemon (Matrix Science) to an in-house MASCOT sever and Distiller. The protein ratios used for relative quantitation were calculated as described previously (Yao et al., 2011) .
Kinesin ATPase assays
A commercial Kinesin ELIPA Biochem Kit (Cytoskeleton, BK060) was used to measure KIF4A motor ATPase activity. Recombinant full-length KIF4A was pre-incubated with indicated kinase in a final volume of 15 μl for 30 min at 30˚C to prepare the phosphorylated motor protein. The microtubule ELIPA mix was created at room temperature by mixing 1 ml of reaction buffer (15 mM Pipes-KOH pH 7, 5 mM MgCl 2 ), 10 μl of 2 mM taxol, 80 μl of pre-reconstituted microtubules (1 mg/ml tubulin, 15 mM Pipes-KOH pH 7, 5 mM MgCl 2 , 1 mM GTP, and 20 μM taxol), 240 μl of 1 mM 2-amino-6-mercapto-7-methylpurine riboside, and 12 μl of 0.1 U/μl purine nucleoside phosphorylase. Reactions were set up in 96-well plates by mixing 10 μl of prepared motor protein mixture with 177 μl of the microtubule ELIPA mix. To start the assay, 13 μl of 10 mM ATP was added to each well. Final assay volume was 200 μl of 13.2 mM Pipes-KOH pH 7, 4.4 mM MgCl 2 , and 0.65 mM ATP. The plate was rapidly transferred to 37˚C plate reader (SpectraMax M5, Molecular Devices) and read absorbance at 360 nm every 30 sec for 50 min. A standard curve was created using the phosphate standard in the same assay buffer. Absorbance of each reaction was converted to nanomoles of ATP hydrolyzed according the phosphate standard curve.
Fixed and live cell microscopy
For fixed cell imaging, cells were grown on poly-L-lysinecoated 12-mm glass coverslips and pre-extracted with PEM buffer (100 mM PIPES, PH 6.8, 5 mM EGTA, 2 mM MgCl 2 , 5 nM taxol, and 0.05% Triton) for 20 sec at room temperature before fixation in 3.7% paraformaldehyde for 10 min. The fixed cells were incubated with 0.2% Triton in PBS for 5 min and then blocked with 5% BSA in PBS for 1 h. The primary antibodies were incubated overnight at 4˚C and followed by incubation with Alexa Fluor 488-and Alexa Fluor 555-secondary antibodies at room temperature for 1 h. Affinity-purified antibodies were used at 1 μg/ml, whereas commercial antibodies were used as recommended by manufacturers. Coverslips were mounted in mounting medium (Dako). Images were acquired using a laserscanning confocal microscope imaging system (LSM 710; Carl Zeiss) with a Plan Apochromat 63×, NA 1.4 oil immersion objective. For Figure 4B , z sections were acquired at 0.4 μm steps, and all sections were maximum intensity projected into one picture by ZEN 2012 software (Carl Zeiss). For Figures 4D and 8D , central spindle length was measured by ZEN 2012 software (Carl Zeiss). For quantification in Figure 7E and F and Supplementary Figure S5E , we measured the fluorescence intensity of the regions of interest and subtracted the background by ZEN 2012 software (Carl Zeiss). All images were cropped in Photoshop CS4 and placed into Illustrator CS3 (Adobe) to produce the figures.
All live cell images were captured on the spinning-disc confocal microscope using a 60× magnification water lens (Opera TM LX confocol high content screening system, Perkin Elmer). Cells were grown on poly-L-lysine-coated glass bottom 24-well plates (NEST Biotechnology), and maintained at 37˚C, 5% CO 2 and 80% humidity with opera climate control system software. EGFP labeled proteins were exposed 160 ms using 400 μw 488-nm laser power. Bright cells were exposed 80 ms using 50% LED (690-nm). Time-lapse images were collected every 1-3 min using opera kinetic control software. Z stacks of 15 planes with a spacing of 0.6 μm were taken. Time-lapse images were spliced in sequence and maximum intensity projection was performed. For live imaging of eGFP-KIFA4A, single image collected at the center plane of the image stack is shown in Figure 7C , and maximum intensity projected images are supplied in Supplemental videos. The anaphase central spindle length in Figure 2I and fluorescence intensity of the regions of interest in Figure 7D were measured in Volocity (Perkin Elmer). All tiff files exported from Volocity were cropped in Photoshop CS4 and placed into Illustrator CS3 (Adobe) to produce the figures.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
